Brv China-Backed Global Leading Exoskeleton Company Roboct Secures Rmb100 Million Series A+ Financing
Apr 12, 2022•over 3 years ago
Amount Raised
¥100 Million
Round Type
series a
Description
Hangzhou RoboCT Technology Development Co., Ltd., a global leading exoskeleton company, recently completed RMB100 million series A+ financing led by Fortune Capital and followed by Essence Securities, Poly Capital, and existing investor Blue Run Ventures China (BRV China). The new round of financing will be used to strengthen RoboCT's operational and commercialization capabilities and expand its global footprint.
FundzWatch™ Score
77
Medium Activity
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech